Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.

Mygland, A; Vincent, A; Newsom-Davis, J; Kaminski, H; Zorzato, F; Agius, M; Gilhus, N; Aarli, J

Journal article

Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.

Abstract:: BACKGROUND: About 50% of patients with thymoma have paraneoplastic myasthenia gravis (MG). Myositis and myocarditis or neuromyotonia (NMT) will also develop in some. Patients with thymoma-associated MG produce autoantibodies to a variety of neuromuscular antigens, particularly acetylcholine receptor (AChR), titin, skeletal muscle calcium release channel (ryanodine receptor [RyR]), and voltage-gated potassium channels (VGKC). OBJECTIVE: To examine whether neuromuscular autoantibodies in patients with thymoma correlate with specific clinical syndromes. METHODS: Serum and plasma samples from 19 patients with thymoma-associated MG, of whom 5 had myositis and 6 had NMT, underwent testing for antibodies to AChR, titin, RyR, and VGKC. RESULTS: Antibodies to AChR and titin were found in 19 and 17 patients, respectively. Antibodies to RyR correlated with the presence of myositis (P = .03); they were found in all 5 patients with myositis and in only 1 patient with NMT, but also in 4 of 8 patients with neither disease. Antibodies to VGKC were found in 4 patients with NMT, 1 of 3 patients undergoing testing for myositis, and 2 of 7 patients undergoing testing with neither comorbidity. Presence of RyR antibodies correlated with high levels of titin antibodies. CONCLUSIONS: The results appear to distinguish partially between 3 groups of patients with thymoma-associated MG: the first with RyR antibodies and myositis or myocarditis, the second with NMT without RyR antibodies, and the third without RyR antibodies, myositis, or NMT. Differences in the thymoma may underlie these pathologic associations.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Mygland, A., Vincent, A., Newsom-Davis, J., Kaminski, H., Zorzato, F., Agius, M., Gilhus, N., & Aarli, J. (2000). Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. Archives of Neurology, 57(4), 527–531.

MLA Style

Mygland, A, et al. “Autoantibodies in Thymoma-Associated Myasthenia Gravis with Myositis or Neuromyotonia.” Archives of Neurology, vol. 57, no. 4, 2000, pp. 527–31.

Chicago Style

Mygland, A, A Vincent, J Newsom-Davis, et al. 2000. “Autoantibodies in Thymoma-Associated Myasthenia Gravis with Myositis or Neuromyotonia.” Archives of Neurology 57 (4): 527–31.
Print